Update on medicines for smoking cessation.

作者: Mike McDonough

DOI: 10.18773/AUSTPRESCR.2015.038

关键词:

摘要: Persistent cigarette smokers usually have a nicotine addiction. This addiction has chronic relapsing and sometimes remitting course may persist lifelong. Remission can be facilitated by the use of medication as part comprehensive management strategy tailored to individual patient. Nicotine replacement therapy is first-line drug treatment. It available in many formulations. Varenicline also should started before patient stops smoking. Bupropion second-line therapy. associated with an increased risk seizures interactions. While there some evidence that electronic cigarettes might facilitate smoking cessation, quit rates are not yet comparable those drugs approved on Pharmaceutical Benefits Scheme.

参考文章(113)
Fay Y. Lin, Allison M. Dunning, Jagat Narula, Leslee J. Shaw, Heidi Gransar, Daniel S. Berman, James K. Min, Impact of an Automated Multimodality Point-of-Order Decision Support Tool on Rates of Appropriate Testing and Clinical Decision Making for Individuals With Suspected Coronary Artery Disease: A Prospective Multicenter Study Journal of the American College of Cardiology. ,vol. 62, pp. 308- 316 ,(2013) , 10.1016/J.JACC.2013.04.059
Lorien C. Abroms, Ashley L. Boal, Samuel J. Simmens, Judith A. Mendel, Richard A. Windsor, A randomized trial of Text2Quit: a text messaging program for smoking cessation. American Journal of Preventive Medicine. ,vol. 47, pp. 242- 250 ,(2014) , 10.1016/J.AMEPRE.2014.04.010
JR Hughes, LF Stead, T Lancaster, Anxiolytics and antidepressants for smoking cessation. Cochrane Database of Systematic Reviews. ,(2000) , 10.1002/14651858.CD000031
James K Min, Allison Dunning, Fay Y Lin, Stephan Achenbach, Mouaz Al-Mallah, Matthew J Budoff, Filippo Cademartiri, Tracy Q Callister, Hyuk-Jae Chang, Victor Cheng, Kavitha Chinnaiyan, Benjamin JW Chow, Augustin Delago, Martin Hadamitzky, Joerg Hausleiter, Philipp Kaufmann, Erica Maffei, Gilbert Raff, Leslee J Shaw, Todd Villines, Daniel S Berman, CONFIRM Investigators, Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. Journal of the American College of Cardiology. ,vol. 58, pp. 849- 860 ,(2011) , 10.1016/J.JACC.2011.02.074
Scott D. Halpern, Benjamin French, Dylan S. Small, Kathryn Saulsgiver, Michael O. Harhay, Janet Audrain-McGovern, George Loewenstein, Troyen A. Brennan, David A. Asch, Kevin G. Volpp, Randomized trial of four financial-incentive programs for smoking cessation. The New England Journal of Medicine. ,vol. 372, pp. 2108- 2117 ,(2015) , 10.1056/NEJMOA1414293
Catherine Lucas, Jennifer Martin, Smoking and drug interactions Australian Prescriber. ,vol. 36, pp. 102- 104 ,(2013) , 10.18773/AUSTPRESCR.2013.037
H. J. Dargie, W. S. Hillis, I. Ford, K. M. Fox, Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial The Lancet. ,vol. 359, pp. 1269- 1275 ,(2002)
Cheryl Oncken, Gillian Sandra Gould, Colin Mendelsohn, Management of smoking in pregnant women Australian Family Physician. ,vol. 43, pp. 46- 51 ,(2014)
Tim Coleman, Catherine Chamberlain, Mary-Ann Davey, Sue E Cooper, Jo Leonardi-Bee, Pharmacological interventions for promoting smoking cessation during pregnancy Cochrane Database of Systematic Reviews. ,vol. 3, ,(2015) , 10.1002/14651858.CD010078.PUB2
John Stapleton, Robert West, Peter Hajek, Jenny Wheeler, Eleni Vangeli, Zeinab Abdi, Colin O'Gara, Hayden McRobbie, Kirsty Humphrey, Rachel Ali, John Strang, Gay Sutherland, Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice Addiction. ,vol. 108, pp. 2193- 2201 ,(2013) , 10.1111/ADD.12304